AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simpson, K. M.
Right arrow Articles by Cook, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simpson, K. M.
Right arrow Articles by Cook, J. D.
Agricola
Right arrow Articles by Simpson, K. M.
Right arrow Articles by Cook, J. D.

American Journal of Clinical Nutrition, Vol 34, 1469-1478, Copyright © 1981 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

The inhibitory effect of bran on iron absorption in man

KM Simpson, ER Morris and JD Cook

The effects of whole wheat bran and its components on the absorption of nonheme dietary iron were measured using a double isotope technique in human volunteers. When 12 g bran was added to a light meal, absorption decreased by 51 to 74%; this inhibitory effect of bran was shown for meals of both high and low iron availability. Inhibition was not explained by monoferric phytate, the major form of iron in bran, because labeled iron from monoferric phytate was absorbed at least as well as the common pool of nonheme dietary iron. Furthermore, removal of phytate from bran by endogenous phytase did not in itself alter the inhibitory effect of the bran on iron absorption. Studies in which dephytinized bran was separated into a soluble, phosphate-rich fraction and an insoluble, high-fiber fraction indicated that the soluble fraction was more inhibitory than the insoluble fraction.


This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
F. Pizarro, M. Olivares, E. Hertrampf, S. Nunez, M. Tapia, H. Cori, and D. L. de Romana
Ascorbyl palmitate enhances iron bioavailability in iron-fortified bread.
Am. J. Clinical Nutrition, October 1, 2006; 84(4): 830 - 834.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. B Reddy, R. F Hurrell, and J. D Cook
Estimation of nonheme-iron bioavailability from meal composition
Am. J. Clinical Nutrition, April 1, 2000; 71(4): 937 - 943.
[Abstract] [Full Text] [PDF]

Home page
 Food Science and Technology InternationalHome page
C. Martinez, G. Ros, M.J. Periago, G. Lopez, J. Ortuno, and F. Rincon
El acido fitico en la alimentacion humana/Phytic acid in human nutrition
Food Science and Technology International, January 1, 1996; 2(4): 201 - 209.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by The American Society for Nutrition